What’s going on with the Polynovo share price today?

The strong start has dissipated for Polynovo shares.

| More on:
a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Polynovo shares edge 1.54% higher to $1.32 after reaching an intraday high of $1.41 in morning trade 
  • Polynovo chair David Williams again took advantage of the recent share price weakness, buying $231,000 worth of Polynovo shares 
  • The company's share price touched a 52-week low of 83.5 cents earlier this month 

The Polynovo Ltd (ASX: PNV) share price rocketed as high as 8.65% during market open but has since fallen wayside.

At the time of writing, the medical device company’s shares are swapping hands at $1.32, up 1.54%.

This follows the All Ordinaries Index’s (ASX: XAO) lead which rose to an intraday high within the first hour of trade.

However, since then, the broader ASX index has given back its gains to fetch at 7, 328 points, up 0.28%.

Director tops up on Polynovo shares

An insider has again recently taken advantage of the Polynovo share price weakness to top up their holdings.

In its most recent statement, Polynovo revealed that its chair, David Williams picked up more shares.

In total, 181,532 Polynovo shares were bought through his subsidiary, Lawn Views Pty Ltd via an on-market trade.

The indirect acquisition occurred on 13 May, and the average price paid per Polynovo share was $1.2746.

This means that Mr Williams now has around 21.50 million fully paid ordinary Polynovo shares across all his holdings.

The above transaction equated to the value of more than $231,000.

It is worth nothing that in the beginning of May, Polynovo shares touched a 52-week low of 83.5 cents. Since then, a number of directors, particularly Mr Williams have made a series of purchases.

Polynovo share price snapshot

It appears that the latest purchases could be spooking short sellers to close on their positions. ASIC is due to release its short position report mid-week, which will indicate where Polynovo shares are at.

On 9 May, the company had a reported short interest of 10.54%. This puts Polynovo as one of the most shorted shares on the ASX.

Despite this month’s gains, Polynovo shares have fallen by around 50% over the past 12 months.

Based on today’s price, Polynovo commands a market capitalisation of roughly $860.19 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What’s the outlook for the CSL share price in July?

We take a look at what the experts are saying about the biotech company's shares.

Read more »

Photo of a group of scientists cheering while working in a lab as the Race Oncology share price skyrockets today on positive study results
Healthcare Shares

Why is the Race Oncology share price soaring 13% today?

New trial results have excited ASX investors.

Read more »

Rising arrow on a blue graph symbolising a rising share price.
Healthcare Shares

Starphama share price lunges 5% on product relaunch

Early support for Starphama on Thursday has it off to a great start.

Read more »

Man with rocket wings which have flames coming out of them.
Healthcare Shares

Why is the Paradigm share price rocketing 20% higher today?

The Paradigm share price is having a very strong day...

Read more »

A businessman presents a company annual report in front of a group seated at a table
Healthcare Shares

Own Immutep shares? Here are 3 takeaways from the company’s investor update

Investors were mute to the update.

Read more »

A health professional wearing a stethoscope and scrubs shrugs with uncertainty.
Healthcare Shares

Has CSL been growing its dividend?

Is the biotech giant still increasing its dividends in a post-COVID world?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Healthcare Shares

Why is the 4DMedical share price exploding 40% today?

4DMedical signed a three-year, nationwide contract with I-MED Radiology Network.

Read more »

Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratory
Healthcare Shares

What was the Sonic Healthcare share price when it first listed on the ASX?

Sonic Healthcare has an interesting history...

Read more »